# FDA Inspection 1215854 - GPI USA, Inc. - August 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/gpi-usa-inc/a08e5372-2218-4328-a647-6ada19a41ddd
Source feed: FDA_Inspections

> FDA Inspection 1215854 for GPI USA, Inc. on August 25, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215854
- Company Name: GPI USA, Inc.
- Inspection Date: 2023-08-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1215854 - 2023-08-25](https://www.keypedia.com/records/fda_inspections/gpi-usa-inc/f21cb55e-7057-4347-bda5-7f93f0fd82bd)
- [FDA Inspection 1215854 - 2023-08-25](https://www.keypedia.com/records/fda_inspections/gpi-usa-inc/d3509ada-ead8-435c-a7c1-95a5175d7c1d)

Company: https://www.keypedia.com/companies/gpi-usa-inc/bfa89195-4ffe-4a1b-82d5-cfc5bb257254

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d